Company mentioned on podcasts
Anthos Therapeutics
Mentioned on 1 episode by 1 guest across our covered podcasts.
SignalCast may earn commission on purchases via these links. As an Amazon Associate, SignalCast earns from qualifying purchases.
Who mentioned it
“The Anthos Therapeutics model—carving abelacimab from Novartis in 2019, running phase two trials showing 62–89% bleeding reduction versus Xarelto, publishing in NEJM twice, then selling back to Novartis for $3.1B”
Mentioned on: Pathfinders in Biopharma